ORIG3N™ Closes Latest Round of Funding; Welcomes New Board Member and New Investor

ORIG3N™ Closes Latest Round of Funding; Welcomes New Board Member and New Investor

Funding will support accelerated growth and intensification of research and development efforts


Jun 27, 2017, 09:00 ET

BOSTONJune 27, 2017 /PRNewswire/ — ORIG3N, Inc., a Boston-based biomedical research company, has announced the addition of Byron Smith to its Board of Directors and Spectrum Health Ventures (SHV) to its investor syndicate. The announcements come on the heels of the close of ORIG3N’s latest round of funding. ORIG3N has raised over $30 million in capital to date since it was founded in 2014.

Byron Smith brings decades of industry experience to ORIG3N’s board of directors. Mr. Smith is currently a Principal at Mountain Group Partners (MGP), a Fund dedicated to investing in and guiding transformation businesses in the life science and technology sectors. Prior to his involvement with MGP, Mr. Smith held a long and distinguished career in the wireless and tech spaces. He began his career in brand management and advertising, before moving to Silicon Valley and transitioning into tech, where he gained experience in media/content and internet technology/infrastructure. Now, back on the East Coast, Mr. Smith serves on or has visitation rights to the board of directors of many companies in the health services sector.


0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © Spectrum Health Ventures. All Rights Reserved.